scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 8,320,407
- Share change
- +513,735
- Total reported value
- $103,170,760
- Price per share
- $12.40
- Number of holders
- 37
- Value change
- +$6,465,196
- Number of buys
- 29
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 810648105:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.4%
|
3,409,865
|
$41,225,000 | — | 31 Dec 2017 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.4%
|
2,857,143
|
$34,543,000 | — | 31 Dec 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.57%
|
304,709
|
$3,684,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
0.37%
|
200,000
|
$2,418,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.34%
|
180,000
|
$2,177,000 | — | 31 Dec 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.33%
|
175,000
|
$2,116,000 | — | 31 Dec 2017 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.31%
|
165,100
|
$1,996,000 | — | 31 Dec 2017 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.23%
|
124,074
|
$1,500,000 | — | 31 Dec 2017 | |
| Bain Capital Public Equity Management, LLC |
13F
|
Company |
0.2%
|
106,794
|
$1,291,000 | — | 31 Dec 2017 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.18%
|
98,100
|
$1,186,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
54,032
|
$653,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
38,182
|
$462,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
34,269
|
$414,000 | — | 31 Dec 2017 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
12,963
|
$157,000 | — | 31 Dec 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
9,445
|
$114,000 | — | 31 Dec 2017 | |
| NORGES BANK |
13F
|
Company |
0.02%
|
9,000
|
$109,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
5,065
|
$61,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
1,364
|
$16,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,108
|
$13,000 | — | 31 Dec 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
617
|
$7,000 | — | 31 Dec 2017 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
357
|
$4,000 | — | 31 Dec 2017 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
350
|
$4,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
200
|
$2,000 | — | 31 Dec 2017 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q1 2018
As of 31 Mar 2018,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,320,407 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Alyeska Investment Group, L.P., AWM Investment Company, Inc., VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
24
Q1 2018 holders
37
Holder diff
13
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.